alexa Why Treat Chronic Total Occlusion without Stents? - A S
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Commentary

Why Treat Chronic Total Occlusion without Stents? - A Short Comment

Philine Jascha Köln1* and Franz Xaver Kleber2*

1Charité – Universitätsmedizin Berlin, Berlin, Germany

2Cardio Centrum Berlin, Academic Teaching Institution, Charité – Universitätsmedizin Berlin, Berlin, Germany

*Corresponding Authors:
Philine Jascha Köln
Charité – Universitätsmedizin Berlin, Berlin, Germany
Tel: 49 30 450 -50
E-mail: [email protected]
Franz Xaver Kleber
Cardio Centrum Berlin, Academic Teaching Institution
Charité – Universitätsmedizin Berlin, Berlin, Germany
Tel: 030 20 61 63 63 6
E-mail: [email protected]

Received date: May 26, 2017; Accepted date: June 16, 2017; Published date: June 20, 2017

Citation: Köln PJ, Kleber FX (2017) Why Treat Chronic Total Occlusion without Stents? - A Short Comment. J Clin Exp Cardiolog 8:529. doi: 10.4172/2155-9880.1000529

Copyright: © 2017 Köln PJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



The treatment of chronic total occlusions is complex and associated with several risks and problems. Among therapeutic options including bypass surgery and medical therapy PCI represents an important strategy. PCI with stents, however, has limitations in such lesions due to characteristics like lesion length, unknown reference diameter and delayed stent coverage. Drug coated balloons have shown promising properties to overcome some of those limitations: They promote positive vessel remodeling and have a minimal thrombosis rate. In a first multicenter study it has been shown that drug coated balloons in proper indications and applied with appropriate technique might become a new treatment option for patients with chronic total occlusions.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version